180 related articles for article (PubMed ID: 36558080)
1. Target Identification of 22-(4-Pyridinecarbonyl) Jorunnamycin A, a Tetrahydroisoquinoline Derivative from the Sponge
Iksen I; Sinsook S; Wattanathamsan O; Buaban K; Chamni S; Pongrakhananon V
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558080
[TBL] [Abstract][Full Text] [Related]
2. Light-Mediated Transformation of Renieramycins and Semisynthesis of 4'-Pyridinecarbonyl-Substituted Renieramycin-Type Derivatives as Potential Cytotoxic Agents against Non-Small-Cell Lung Cancer Cells.
Sinsook S; Buaban K; Iksen I; Petsri K; Innets B; Chansriniyom C; Suwanborirux K; Yokoya M; Saito N; Pongrakhananon V; Chanvorachote P; Chamni S
Mar Drugs; 2023 Jul; 21(7):. PubMed ID: 37504931
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Characterization of 22-(4'-Pyridinecarbonyl) Jorunnamycin A against Lung Cancer Cell Invasion and Angiogenesis
Iksen I; Seephan S; Limprasutr V; Sinsook S; Buaban K; Chamni S; Pongrakhananon V
ACS Pharmacol Transl Sci; 2023 Aug; 6(8):1143-1154. PubMed ID: 37588759
[TBL] [Abstract][Full Text] [Related]
4. 5-O-Acetyl-Renieramycin T from Blue Sponge Xestospongia sp. Induces Lung Cancer Stem Cell Apoptosis.
Chantarawong W; Chamni S; Suwanborirux K; Saito N; Chanvorachote P
Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30754694
[TBL] [Abstract][Full Text] [Related]
5. Chemistry of Renieramycins. 15. Synthesis of 22-O-Ester Derivatives of Jorunnamycin A and Their Cytotoxicity against Non-Small-Cell Lung Cancer Cells.
Sirimangkalakitti N; Chamni S; Charupant K; Chanvorachote P; Mori N; Saito N; Suwanborirux K
J Nat Prod; 2016 Aug; 79(8):2089-93. PubMed ID: 27487087
[TBL] [Abstract][Full Text] [Related]
6. Chemistry of Renieramycins. 17. A New Generation of Renieramycins: Hydroquinone 5-O-Monoester Analogues of Renieramycin M as Potential Cytotoxic Agents against Non-Small-Cell Lung Cancer Cells.
Chamni S; Sirimangkalakitti N; Chanvorachote P; Saito N; Suwanborirux K
J Nat Prod; 2017 May; 80(5):1541-1547. PubMed ID: 28459574
[TBL] [Abstract][Full Text] [Related]
7. Semisynthesis of 5-O-ester derivatives of renieramycin T and their cytotoxicity against non-small-cell lung cancer cell lines.
Buaban K; Innets B; Petsri K; Sinsook S; Chanvorachote P; Chansriniyom C; Suwanborirux K; Yokoya M; Saito N; Chamni S
Sci Rep; 2023 Dec; 13(1):21485. PubMed ID: 38057385
[TBL] [Abstract][Full Text] [Related]
8. Jorunnamycin A Suppresses Stem-Like Phenotypes and Sensitizes Cisplatin-Induced Apoptosis in Cancer Stem-Like Cell-Enriched Spheroids of Human Lung Cancer Cells.
Sumkhemthong S; Chamni S; Ecoy GU; Taweecheep P; Suwanborirux K; Prompetchara E; Chanvorachote P; Chaotham C
Mar Drugs; 2021 May; 19(5):. PubMed ID: 34063628
[TBL] [Abstract][Full Text] [Related]
9. Renieramycin T Induces Lung Cancer Cell Apoptosis by Targeting Mcl-1 Degradation: A New Insight in the Mechanism of Action.
Petsri K; Chamni S; Suwanborirux K; Saito N; Chanvorachote P
Mar Drugs; 2019 May; 17(5):. PubMed ID: 31117253
[TBL] [Abstract][Full Text] [Related]
10. Jorunnamycin A from
Ecoy GAU; Chamni S; Suwanborirux K; Chanvorachote P; Chaotham C
J Nat Prod; 2019 Jul; 82(7):1861-1873. PubMed ID: 31260310
[TBL] [Abstract][Full Text] [Related]
11. Inhibition effect of oxyepiberberine isolated from Coptis chinensis franch. On non-small cell lung cancer based on a network pharmacology approach and experimental validation.
Zhang Y; Yao Y; Fu Y; Yuan Z; Wu X; Wang T; Hong Z; Yang Y; Wu H
J Ethnopharmacol; 2021 Oct; 278():114267. PubMed ID: 34087401
[TBL] [Abstract][Full Text] [Related]
12. The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking.
Zou T; Huang Y; Hu Y; Wu M; Zhao Y; Du F; Li M; Wu X; Ji H; Kaboli PJ; Wang S; Xiao Z; Wu Z
Recent Pat Anticancer Drug Discov; 2021; 16(3):426-435. PubMed ID: 33573560
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis-inducing Effect of Hydroquinone 5-
Maiuthed A; Pinkhien T; Chamni S; Suwanborirux K; Saito N; Petpiroon N; Chanvorachote P
Anticancer Res; 2017 Nov; 37(11):6259-6267. PubMed ID: 29061809
[TBL] [Abstract][Full Text] [Related]
14. Schizandrin A induces non-small cell lung cancer apoptosis by suppressing the epidermal growth factor receptor activation.
Zhu L; Wang Y; Huang X; Liu X; Ye B; He Y; Yu H; Lv W; Wang L; Hu J
Cancer Med; 2024 Jan; 13(2):e6942. PubMed ID: 38376003
[TBL] [Abstract][Full Text] [Related]
15. Identifying molecular targets of Aspiletrein-derived steroidal saponins in lung cancer using network pharmacology and molecular docking-based assessments.
Iksen I; Witayateeraporn W; Wirojwongchai T; Suraphan C; Pornputtapong N; Singharajkomron N; Nguyen HM; Pongrakhananon V
Sci Rep; 2023 Jan; 13(1):1545. PubMed ID: 36707691
[TBL] [Abstract][Full Text] [Related]
16. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF
Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974
[TBL] [Abstract][Full Text] [Related]
17. Casticin and chrysosplenol D from Artemisia annua L. induce apoptosis by inhibiting topoisomerase IIα in human non-small-cell lung cancer cells.
Fu C; Zhang K; Wang M; Qiu F
Phytomedicine; 2022 Jun; 100():154095. PubMed ID: 35398735
[TBL] [Abstract][Full Text] [Related]
18. Identification of the Active Compounds and Significant Pathways of Artemisia Annua in the Treatment of Non-Small Cell Lung Carcinoma based on Network Pharmacology.
Zhang SQ; Xu HB; Zhang SJ; Li XY
Med Sci Monit; 2020 May; 26():e923624. PubMed ID: 32474568
[TBL] [Abstract][Full Text] [Related]
19. Systems pharmacology unravels the synergic target space and therapeutic potential of Rhodiola rosea L. for non-small cell lung cancer.
Zhang X; Zhu J; Yan J; Xiao Y; Yang R; Huang R; Zhou J; Wang Z; Xiao W; Zheng C; Wang Y
Phytomedicine; 2020 Dec; 79():153326. PubMed ID: 32992083
[TBL] [Abstract][Full Text] [Related]
20. Aloe emodin 3-O-glucoside inhibits cell growth and migration and induces apoptosis of non-small-cell lung cancer cells via suppressing MEK/ERK and Akt signalling pathways.
Kim HJ; Choi JW; Ree J; Lim JS; Lee J; Kim JI; Thapa SB; Sohng JK; Park YI
Life Sci; 2022 Jul; 300():120495. PubMed ID: 35341826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
